Objective Evaluation of Untargeted Metabolomic Methods Based on Data-Dependent Acquisition and Public Spectral Databases
Analytical Chemistry · 19.11.2026
DOI: 10.1021/acs.analchem.6c03292 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Chemistry, online erschienen am 19.11.2026. Verfasst von Romina Pacheco-Tapia und 8 weiteren Autor:innen. Die Arbeit nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universit? de Lille, Agence Nationale de la Recherche, European Research Council.
Abstract (Originalsprache)
Untargeted metabolomics based on Ultra High-Performance Liquid Chromatography coupled to High-Resolution Mass Spectrometry (UHPLC-HRMS) is a powerful tool widely used in various research domains, including large-scale clinical studies. However, current approaches for comparing untargeted metabolomic methods typically rely on a limited set of representative analytes due to their high cost and limited availability, potentially introducing bias given the vast chemical diversity of the detectable metabolome. This study proposes a data-driven strategy to systematically compare and rank untargeted UHPLC-HRMS methodologies by leveraging metabolite annotations from the public reference spectral libraries deposited in the Global Natural Products Social molecular network (GNPS) as a proxy for chemical coverage. We assessed 23 methodologies: 15 reverse-phase and 8 HILIC-phase from six metabolomic platforms using commercial human serum samples. Across all methods, a combined total of 2448 unique metabolites were annotated at MSI level 2, covering 57 chemical classes and 13 superclasses, as defined by the ClassyFire ontology. Methods were ranked using a weighted composite system incorporating reproducibility (RSD <30%), linearity (Pearson r > 0.9), and chemical diversity coverage quantified by the Shannon diversity index. The reliability of GNPS-based annotations was validated against 129 metabolites for which authentic standards were available in our in-house library, all of which were correctly confirmed, supporting the reliability of the MSI level 2 annotations. Applied to clinical serum samples from the PrevenDIAB study, the best-performing method combination (P1−H and P6−C18) detected 883 metabolites meeting both quality criteria, of which 98% were shared with the commercial serum results. Our findings demonstrate that this framework provides a practical, scalable, and cost-effective complementary approach to standard-based validation for the comparative evaluation of untargeted metabolomics methods.
Förderung
- Universit? de Lille
- Agence Nationale de la Recherche
- European Research Council
- NIHR Imperial Biomedical Research Centre
- Diabetes UK
- Guts UK Charity
- National Center for Diabetes Precision Medicine
- Medical Research Council (MRC)
Zitieren
APA
Pacheco-Tapia, R., Castro-Dionicio, I., Chevalier, M., Berthier, C., Lecerf, J., Bonnefond, A., Froguel, P., Puig-Castellví, F., & Dumas, M. (2026). Objective Evaluation of Untargeted Metabolomic Methods Based on Data-Dependent Acquisition and Public Spectral Databases. Analytical Chemistry. https://doi.org/10.1021/acs.analchem.6c03292
Vancouver
Pacheco-Tapia R, Castro-Dionicio I, Chevalier M, Berthier C, Lecerf J, Bonnefond A, et al. Objective Evaluation of Untargeted Metabolomic Methods Based on Data-Dependent Acquisition and Public Spectral Databases. Analytical Chemistry. 2026. doi:10.1021/acs.analchem.6c03292
BibTeX
@article{PachecoTapia2026,
author = {Pacheco-Tapia, Romina and Castro-Dionicio, Inés and Chevalier, Mickaël and Berthier, Coralie and Lecerf, Jean-Michel and Bonnefond, Amélie and Froguel, Philippe and Puig-Castellví, Francesc and Dumas, Marc-Emmanuel},
title = {Objective Evaluation of Untargeted Metabolomic Methods Based on Data-Dependent Acquisition and Public Spectral Databases},
journal = {Analytical Chemistry},
year = {2026},
doi = {10.1021/acs.analchem.6c03292}
}
EUVIMED